Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Wellnex Life Ltd ( (AU:WNX) ) has shared an announcement.
Wellnex Life Ltd has launched a 1:1 non-renounceable entitlement offer to raise up to $22.1 million, aligned with its proposed dual listing on the London Stock Exchange’s AIM market. The funds will be used to redeem convertible notes and pay outstanding deferred costs for Pain Away, resulting in annual savings of $1.4 million and supporting general working capital needs. This strategic move aims to ensure existing shareholders participate equally with UK investors and marks a transformational step in Wellnex Life’s global expansion strategy.
More about Wellnex Life Ltd
Wellnex Life Ltd is a dynamic consumer healthcare business with a diverse portfolio of proprietary brands and licensing agreements. The company has developed its brands like Wakey Wakey and Nighty Night, and acquired Pain Away in 2023. It also holds intellectual property licensing deals with global pharmaceutical entities, including Haleon. Wellnex Life reported significant revenue growth of 112% for H1 FY25, driven by a 182% increase in brand sales and a 64% rise in IP licensing.
YTD Price Performance: 17.50%
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €18.83M
For detailed information about WNX stock, go to TipRanks’ Stock Analysis page.
